In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Special Interest Projects (SIP) 15-002, Economic Impact of Clinical Trials among Children Diagnosed with Cancer, and, SIP 15-005, Economic Costs of Quality Assurance in Lung Cancer Screening Programs.
Time and Date: 11:00 a.m.-6:00 p.m., May 19, 2015.
Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to “Economic Impact of Clinical Trials among Children Diagnosed with Cancer, SIP 15-002, and, Economic Costs of Quality Assurance in Lung Cancer Screening Programs, SIP 15-005.”
Contact Person for More Information: Brenda Colley Gilbert, Ph.D., M.S.P.H., Director, Extramural Research Program Operations and Services, CDC, 4770 Buford Highway NE., Mailstop F-80, Atlanta, Georgia 30341, Telephone: (770) 488-6295, BJC4@cdc.gov.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2015-09645 Filed 4-24-15; 8:45 am]
BILLING CODE 4163-18-P